Dr. Kathryn McGonigle is board certified by the American Board of Obstetrics and Gynecology with certification of Special Qualification in Gynecologic Oncology. She received her undergraduate degree at the University of Notre Dame in Indiana and graduated cum laude from the St. Louis University School of Medicine. She completed a residency in obstetrics and gynecology at University of California, San Francisco in 1988 and a fellowship in gynecologic oncology at UCLA in 1993. She taught at Johns Hopkins University School of Medicine and the UCLA School of Medicine. She has trained dozens of fellows and residents and has held faculty positions at UC Irvine, UCLA and the University of Washington. She is also a clinical associate professor at the University of Washington and is actively involved in the education of UW Medical students and pelvic surgery fellows. Dr. McGonigle is a member of Alpha Omega Alpha, a medical honor society.
Her particular research and clinical interests include:
- Treatments for recurrent ovarian, fallopian tube and primary peritoneal carcinomas
- Clinical trials of novel treatments for patients with primary or recurrent ovarian cancer
- Genetic risks of ovarian, breast, and uterine cancer.
Dr. McGonigle weighs in on...
|Dr. McGonigle speaks out about Surgical Management of Ovarian Cancer: Challenges and Opportunitiese.
|Dr. McGonigle talks about BRCA testing on KIRO radio. Listen now...
||Dr. Kathryn McGonigle recently appeared on "Ring my Belle, with Rachel Belle" on KIRO radio to talk about BRCA gene testing. Rachel asked the question: if you could find out if you had a cancer gene that would elevate your chances of getting breast or ovarian cancer, would you want to know? Listen to hear what Dr. McGonigle and two cancer survivors had to say about the making this decision. Click here to listen.|
Dr. Howard G. Muntz is board certified by the American Board of Obstetrics and Gynecology with certification of Special Qualification in Gynecologic Oncology. Dr. Muntz was a member of Phi Beta Kappa at Vanderbilt University in Nashville, TN. He spent 13 years at Harvard Medical School, first as a medical student (class of 1984) and then as a resident in obstetrics and gynecology at the Harvard-affiliated Brigham and Women's Hospital and Massachusetts General Hospital. He also had additional training in gynecologic cancer as the American Cancer Society Clinical Fellow at Massachusetts General Hospital.
While at Harvard Medical School, Dr. Muntz served as an assistant professor in the Department of Obstetrics, Gynecology and Reproduction Biology and was a member of the medical staff at Boston's Beth Israel Hospital and the Dana Farber Cancer Institute. After moving to Seattle, Dr. Muntz has continued his interest in medical education at the University of Washington, where he is a clinical professor.
His particular research interests include:
- Evaluation of treatment regimens for gynecologic malignancies, including trials of novel therapies for ovarian carcinoma
- Early diagnosis of ovarian cancer
- Evaluation of socioeconomic factors in the delivery of gynecologic oncology care in the United States
- Evaluation and treatment of pre-neoplastic lesions of the lower genital tract
- Preservation of fertility in women with cervical adenocarcinoma in situ